Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuro.io is an Artificial Intelligence-as-a-Service (AIaaS) and MLOps platform provider that enables organizations to build, deploy, and scale deep learning models. While serving multiple industries, the company has a significant focus on the life sciences and healthcare sectors, providing the computational infrastructure and tools necessary for complex tasks such as medical imaging analysis, genomic sequencing, and AI-driven drug discovery. Their platform streamlines the machine learning lifecycle, allowing researchers to manage large datasets and high-performance computing resources efficiently. By offering a unified environment for model development and deployment, Neuro.io helps biotech and pharmaceutical companies accelerate their digital transformation and R&D efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuro.io.